The global blood brain barrier market offers potential advantages of delivering therapeutic drugs directly to the brain while reducing systemic exposure. Products like nanocarriers and nanoparticles help improve the pharmacokinetics and biodistribution of drugs. The blood brain barrier presents major challenges for treating many neurological disorders by restricting the passage of molecules from circulating blood into the extracellular fluid of the central nervous system.
The Global Blood Brain Barrier Market is estimated to be valued at US$ 36.2 Mn in 2024 and is expected to exhibit a CAGR of 49.% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the global blood brain barrier market are Denali Therapeutics, JCR Pharmaceuticals, Cyclenium Pharma, Lauren Sciences, biOasis Technologies.
The growing incidence of neurological disorders such as Alzheimer’s disease, epilepsy, meningitis, trauma etc is driving the demand for drugs that can cross the blood brain barrier. According to the WHO, over 50 million people suffer from epilepsy and close to 50 million people have Alzheimer’s disease worldwide.
Companies are focusing on expanding to emerging markets in Asia Pacific and Latin America due to high unmet need and increasing healthcare expenditure. The APAC blood brain barrier market is projected to exhibit a CAGR exceeding 40% over the forecast period due to rising disposable incomes, growing awareness and government initiatives.
Market Key Trends
One of the major trends gaining traction in the blood brain barrier market is the increasing research on nanoparticles. Nanoparticles offer unique properties to traverse the blood brain barrier and deliver payloads specifically to the brain or central nervous system. Various nanocarrier formulations like nanogels, solid lipid nanoparticles and exosomes are being explored for their ability to achieve targeted delivery to the brain. Clinical trials evaluating the potential of nanomedicines to treat brain disorders like glioblastoma and Alzheimer’s are ongoing. This presents immense opportunities for market players.
Porter’s Analysis
Threat of new entrants: High R&D and capital costs of establishing facility for brain barrier research acts as deterrent.
Bargaining power of buyers: Large pharmaceutical companies have more bargaining power over small biotech firms developing brain barrier technologies.
Bargaining power of suppliers: Suppliers of raw materials and reagents have lower bargaining power due to availability of substitute options.
Threat of new substitutes: Alternate routes of drug delivery research may emerge as substitutes over time.
Competitive rivalry: Intense competition among firms to develop novel techniques for delivering therapeutics across blood brain barrier.
Geographical Regions
North America currently holds the largest market share mainly attributed to rising investments in neuroscience research from biopharma companies and government institutions in the US and Canada. Advancements in techniques like liposomes and nanoparticles for drug delivery across blood brain barrier have strengthened North America’s position.
Asia Pacific region is poised to witness the fastest growth over the forecast period credited to expanding healthcare infrastructure, growing disposable incomes, and increasing government focus on neurodegenerative disorder research in countries like China, India and South Korea offering lucrative opportunities for market players.
What Are The Key Data Covered In This Global Blood Brain Barrier Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Blood Brain Barrier Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Blood Brain Barrier Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Blood Brain Barrier Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Blood Brain Barrier Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Blood Brain Barrier Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Blood Brain Barrier Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Blood Brain Barrier Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it